Role of bifidobacteria in the hydrolysis of chlorogenic acid

Stefano Raimondi, Andrew Anighoro, Andrea Quartieri, Alberto Amaretti, Francisco A. Tómas‐Barberán, Giulio Rastelli, Maddalena RossiMicrobiologyOpen 2014 · DOI

TL;DR

This study identifies Bifidobacterium animalis as a key player in breaking down chlorogenic acid (CGA) into caffeic acid (CA), a more bioavailable and potentially beneficial compound. They pinpointed a specific intracellular enzyme, Balat_0669, responsible for this hydrolysis, paving the way for developing probiotics optimized for phytochemical bioconversion.

What Problem Does This Paper Address?

Many beneficial compounds found in plants, like chlorogenic acid (CGA), are not readily absorbed by the human body in their native form. The gut microbiota plays a crucial role in transforming these complex molecules into more bioavailable and active forms. However, the specific contributions of different gut bacteria, particularly probiotic strains like Bifidobacteria, to this process are not fully understood. This paper addresses the question of which Bifidobacterium species can hydrolyze CGA into caffeic acid (CA) and identifies the enzymatic machinery responsible for this transformation, aiming to leverage this knowledge for improved health benefits from dietary polyphenols.

Methods

The researchers employed a multi-pronged approach:

  • Microbial Screening: They screened 32 Bifidobacterium strains from eight different species to assess their ability to hydrolyze CGA into CA. This involved culturing the bacteria in the presence of CGA and measuring the resulting CA concentration.
  • Enzyme Identification (In Silico): Using bioinformatics tools, they searched for esterase genes within the genomes of Bifidobacterium species, specifically looking for homologs of known CGA-hydrolyzing enzymes. They used sequence alignment and prediction tools (SignalP, SecretomeP) to infer protein localization.
  • Structural Biology (In Silico): For a candidate enzyme (Balat_0669), they built a 3D structural model using homology modeling and then performed molecular docking simulations to predict how CGA would bind to the enzyme's active site.
  • Molecular Biology and Biochemistry: They cloned the gene for Balat_0669 into E. coli for heterologous expression. They then purified the recombinant enzyme and characterized its activity by measuring its ability to hydrolyze CGA.
  • Enzyme Localization Studies: They investigated whether the CGA hydrolysis activity was intracellular or extracellular by analyzing cell-free extracts, resting cells, and supernatants from Bifidobacterium cultures.

Datasets

Not discussed in the paper. The study primarily relies on screening of bacterial strains and analysis of their genomes.

Key Insights and Ideas

  • Specificity of Hydrolysis: The ability to hydrolyze CGA into CA is not universal among Bifidobacterium species. It appears to be largely confined to Bifidobacterium animalis subspecies. This highlights the importance of strain-level specificity in probiotic function.
  • Intracellular Enzyme Action: The key enzyme responsible for CGA hydrolysis in B. animalis is intracellular (cytosolic). This means that the bacteria need to internalize the CGA or that the hydrolysis occurs after cell lysis or during specific growth phases.
  • Balat_0669 as the Culprit: The study successfully identified Balat_0669, an esterase found in B. animalis, as the likely enzyme responsible for CGA hydrolysis. This was supported by in silico predictions and confirmed through heterologous expression and functional assays.
  • Structural Basis for Catalysis: Molecular modeling and docking provided strong evidence that Balat_0669's active site is well-suited to bind and hydrolyze CGA, with the ester bond positioned favorably for enzymatic action.
  • Probiotic Potential for Bioactivation: This research opens doors for developing probiotics specifically selected for their ability to bioconvert dietary phytochemicals into more bioactive forms, enhancing their health benefits.

Key Results

  • Out of 32 Bifidobacterium strains screened, only 10 hydrolyzed CGA into CA. All nine strains of B. animalis subspecies tested showed this activity, along with one strain of B. longum subsp. infantis.
  • B. animalis subsp. lactis WC 0432 was the most effective strain, achieving up to 88.6% CGA hydrolysis under controlled pH conditions.
  • The enzyme responsible for hydrolysis in B. animalis was found to be intracellular.
  • In silico analysis identified Balat_0669 as a strong candidate enzyme, showing high similarity to known cinnamoyl esterases.
  • Heterologous expression of Balat_0669 in E. coli resulted in a functional enzyme that efficiently converted CGA to CA (91% conversion within 1 hour).
  • The purified recombinant Balat_0669 enzyme exhibited a specific activity of 2.5 U/mg, significantly higher than in crude cell lysates.

Limitations and Future Work

  • In Vitro vs. In Vivo: While the study demonstrates the enzymatic capability in vitro, the actual extent of CGA hydrolysis by B. animalis in the complex environment of the human gut remains to be fully elucidated. The authors note that in a previous study, B. animalis did not significantly increase CA flux, possibly due to competition from other metabolic pathways like hydrogenation.
  • Substrate Specificity Beyond CGA: The study briefly mentions dihydrochlorogenic acid (DHPP-QA) as a potential substrate. Further investigation into the enzyme's broader substrate range and its role in metabolizing other hydroxycinnamic acids would be valuable.
  • Strain Variability: While B. animalis as a species showed hydrolysis, the efficiency varied among strains. Future work could focus on identifying and characterizing the most potent strains for probiotic applications.
  • Mechanism of Release: The intracellular nature of the enzyme raises questions about how CGA is accessed. Further research could explore potential transport mechanisms or the role of cell lysis in releasing the enzyme or its products.
  • Clinical Relevance: While the study provides a strong mechanistic basis, translating these findings into direct health benefits through probiotic intervention requires further clinical studies.

Summary updated

Abstract

This study aimed to explore the capability of potentially probiotic bifidobacteria to hydrolyze chlorogenic acid into caffeic acid (CA), and to recognize the enzymes involved in this reaction. Bifidobacterium strains belonging to eight species occurring in the human gut were screened. The hydrolysis seemed peculiar of Bifidobacterium animalis, whereas the other species failed to release CA. Intracellular feruloyl esterase activity capable of hydrolyzing chlorogenic acid was detected only in B. animalis. In silico research among bifidobacteria esterases identified Balat_0669 as the cytosolic enzyme likely responsible of CA release in B. animalis. Comparative modeling of Balat_0669 and molecular docking studies support its role in chlorogenic acid hydrolysis. Expression, purification, and functional characterization of Balat_0669 in Escherichia coli were obtained as further validation. A possible role of B. animalis in the activation of hydroxycinnamic acids was demonstrated and new perspectives were opened in the development of new probiotics, specifically selected for the enhanced bioconversion of phytochemicals into bioactive compounds.
BibTeX
@inproceedings{raimondi2014role,
  author = {Stefano Raimondi and Andrew Anighoro and Andrea Quartieri and Alberto Amaretti and Francisco A. Tómas‐Barberán and Giulio Rastelli and Maddalena Rossi},
  title = {{Role of bifidobacteria in the hydrolysis of chlorogenic acid}},
  booktitle = {MicrobiologyOpen},
  year = {2014},
  doi = {10.1002/mbo3.219},
}
Figure